Validation of the French version of the PAWSS scale for alcohol withdrawal prediction

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to validate the French version of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in patients with Alcohol Use Disorders (AUDs). Participants will be hospitalized and followed for three days, during which they will complete various scales and surveys, including the French PAWSS and other relevant assessments. The study seeks to determine if the psychometric properties of the French version are comparable to those of the English version, thereby enhancing the management of alcohol withdrawal syndrome in French-speaking populations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male or female, aged 18 to 60 years
* Subjects with DSM-5 criteria for alcohol use disorders (AUD)
* Subjects hospitalized for scheduled withdrawal or patients developing alcohol withdrawal hospitalized for another reason.
* Subjects who understand French
* Subject affiliated to the French social security system
* Subject having given their written consent to the study

Exclusion Criteria:

* Subjects transferred from other hospitalization services for whom a withdrawal syndrome could have already been treated.
* Subjects scheduled for discharge within 48 hours.
* Subjects with known uncontrolled epilepsy.
* Subjects unable to understand the questionnaire.
* Subjects unable to give consent or not volunteering for the study.
* Subjects under guardianship or curatorship.

Where it's running

• Etablissement Public de Santé Barthélemy Durand
  Étampes, France Recruiting

Study contacts

• Principal investigator: Alain Dervaux — Etablissement Public de Santé Barthélemy Durand
• Study coordinator: Adelaide Aduayi
• Email: adelaide.aduayi@eps-etampes.fr
• Phone: +33 1 75 02 16 81

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for adults with alcohol use disorder

  This study will test whether BrainsWay Deep TMS can reduce heavy drinking in adults with moderate to severe alcohol use disorder compared with a sham procedure.

  Recruiting at 9 sites Brainsway · Tuscaloosa, Alabama and 10 other locations · NCT07216872

• Tirzepatide's effects on alcohol intake in patients with schizophrenia and alcohol use disorder

  This study is testing if the medication tirzepatide can help people with schizophrenia and alcohol use disorder drink less alcohol over six months.

  Recruiting at 2 sites Phase 2 Psychiatric Centre Rigshospitalet · Aalborg, Denmark and 1 other locations · NCT06939088

• Exploring the effects of heavy alcohol use on oral health and saliva

  This study is trying to see how heavy drinking affects oral health and inflammation in people with alcohol use disorder compared to those without it.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06684483

• Motivational interviews to help maintain abstinence after alcohol withdrawal

  This study tests if using motivational interviews as extra support can help adults who have just gone through alcohol withdrawal stay sober longer compared to regular care.

  Recruiting University Hospital, Montpellier · Montpellier · NCT06618755

• Ketone supplement to reduce alcohol withdrawal symptoms and change brain metabolism

  This will test whether a 4-day oral ketone supplement can reduce alcohol withdrawal symptoms and alter brain metabolism in adults with moderate to severe alcohol use disorder during inpatient detox.

  Recruiting Phase 2/3 University of Pennsylvania · Philadelphia, Pennsylvania · NCT06559995

• Psilocybin versus ketamine for reducing heavy drinking in alcohol use disorder

  This trial will test whether a single 30 mg dose of psilocybin or a weight-based 0.75 mg/kg dose of ketamine, each given with individual psychotherapy, can reduce heavy drinking in adults with moderate to severe alcohol use disorder.

  Recruiting Phase 2 University of Iowa · Iowa City, Iowa · NCT06405607

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.